Filing Details

Accession Number:
0001209191-22-062349
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-21 17:00:16
Reporting Period:
2022-12-19
Accepted Time:
2022-12-21 17:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1807120 Design Therapeutics Inc. DSGN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534986 Md Joao Siffert C/O Design Therapeutics, Inc.
6005 Hidden Valley Road, Suite 110
Carlsbad CA 92011
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-19 1,150 $8.47 126,319 No 4 P Direct
Common Stock Acquisiton 2022-12-20 6,300 $8.38 132,619 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 1,250 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan ("ESPP") on November 15, 2021 and 1,220 shares acquired under the ESPP on May 13, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.32 to $8.44, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth herein.